null

TAPP1 Monoclonal Antibody (CAB20941)

SKU:
CAB20941
Product Type:
Antibody
Antibody Type:
Polyclonal Antibody
Reactivity:
Human
Rat
Host Species:
Rabbit
Isotype:
IgG
  • Western blot analysis of extracts of various cell lines, using TAPP1 antibody at 1:500 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Enhanced Kit. Exposure time: 120s.
  • Western blot analysis of extracts of various cell lines, using TAPP1 antibody at 1:500 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 90s.
€179 - €469
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

TAPP1 Monoclonal Antibody (CAB20941)

The TAPP1 Polyclonal Antibody (CAB20941) is a valuable tool for researchers studying TAPP1, a protein involved in intracellular signaling pathways. This antibody, produced in rabbits, has high reactivity with human samples and has been validated for use in Western blot applications. By binding specifically to TAPP1, this antibody enables the detection and analysis of TAPP1 in a variety of cell types, making it an essential tool for investigations in cell signaling and signal transduction research.TAPP1 is known to play a crucial role in regulating cellular processes such as cell proliferation, survival, and differentiation through its interaction with various intracellular signaling molecules.

Understanding the function of TAPP1 is important for unraveling its contribution to normal cellular function as well as its potential role in diseases like cancer, diabetes, and neurodegenerative disorders. The TAPP1 Polyclonal Antibody provides researchers with a reliable means to investigate the role of TAPP1 in these contexts, ultimately leading to advancements in our understanding of cellular signaling pathways and potential therapeutic targets.